Compare ELWT & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELWT | TELA |
|---|---|---|
| Founded | 2002 | 2012 |
| Country | United States | United States |
| Employees | 34 | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.6M | 37.5M |
| IPO Year | N/A | 2019 |
| Metric | ELWT | TELA |
|---|---|---|
| Price | $6.12 | $0.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $12.00 | $2.00 |
| AVG Volume (30 Days) | 39.7K | ★ 198.4K |
| Earning Date | 05-15-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 37.59 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $80,275,000.00 |
| Revenue This Year | $167.76 | $10.23 |
| Revenue Next Year | $22.42 | $14.26 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 15.84 |
| 52 Week Low | $4.11 | $0.50 |
| 52 Week High | $8.25 | $2.19 |
| Indicator | ELWT | TELA |
|---|---|---|
| Relative Strength Index (RSI) | 50.22 | 42.52 |
| Support Level | $6.30 | $0.50 |
| Resistance Level | $7.10 | $1.24 |
| Average True Range (ATR) | 0.71 | 0.12 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 58.26 | 31.41 |
Elauwit Connection Inc is a provider of broadband Internet networks for the multifamily and student housing property sector. It designs, installs, operates, and maintains new fiber-optic and WiFi networks throughout each contracted property. Once installed, property owners begin selling Internet connectivity over Elauwit's network directly to their residents at monthly prices and terms of their choosing. Elauwit, in turn, provides all resident activation, onboarding, customer support, and network monitoring and maintenance services in exchange for a fixed monthly fee based on the number of units in the property times a monthly per-unit wholesale price. Its contracts with property owners generally have five to eight-year terms. Geographically, the company mainly operates in the U.S.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.